1.A Case of Hypothyroidism and Type 2 Diabetes Associated with Type V Hyperlipoproteinemia and Eruptive Xanthomas.
Jeong Rang PARK ; Tae Sik JUNG ; Jung Hwa JUNG ; Gyeong Won LEE ; Me Ae KIM ; Ki Jong PARK ; Deok Ryong KIM ; Se Ho CHANG ; Soon Il CHUNG ; Jong Ryeal HAHM
Journal of Korean Medical Science 2005;20(3):502-505
Primary hypothyroidism and type 2 diabetes are both typically associated with the increased level of triglycerides. To date, there have been only a few case reports of type 2 diabetes patients with both type V hyperlipoproteinemia and eruptive xanthomas, but there have been no reports of hypothyroidism patients associated with eruptive xanthomas. We report here on a case of a 48-yr old female patient who was diagnosed with type 2 diabetes and primary hypothyroidism associated with both type V hyperlipoproteinemia and eruptive xanthomas. We found rouleaux formation of RBCs in peripheral blood smear, elevated TSH, and low free T4 level, and dyslipidemia (total cholesterol 18.1 mM/L, triglyceride 61.64 mM/L, HDL 3.0 mM/L, and LDL 2.54 mM/L). She has taken fenofibrate, levothyroxine, and oral hypoglycemic agent for 4 months. After treatment, both TSH level and lipid concentration returned to normal range, and her yellowish skin nodules have also disappeared.
Antilipemic Agents/therapeutic use
;
Diabetes Mellitus, Type 2/blood/*complications/drug therapy
;
Erythrocyte Aggregation
;
Female
;
Humans
;
Hyperlipidemia/blood
;
Hyperlipoproteinemia Type V/blood/*complications/drug therapy
;
Hypoglycemic Agents/therapeutic use
;
Hypothyroidism/blood/*complications/drug therapy
;
Middle Aged
;
Procetofen/therapeutic use
;
Research Support, Non-U.S. Gov't
;
Skin Diseases/blood/complications/drug therapy
;
Thyrotropin/blood/therapeutic use
;
Thyroxine/blood
;
Treatment Outcome
;
Xanthomatosis/blood/*complications/drug therapy